Stryker R&D Facility Boosts Medical Device Testing

It will allow prototyping and product development testing in addition to expanded pre-clinical microbiology testing.

I Stock 1401241572

Stryker established its first R&D facility in India more than 15 years ago and today the company’s footprint continues to expand to meet the healthcare needs of care teams all over the world. In 2022, Stryker strengthened its R&D capabilities by opening a new research and development facility, Stryker’s Global Technology Centre (SGTC), which recently expanded to accommodate rigorous life cycle testing of medical devices, including additional highly skilled engineers and microbiologists to conduct prototyping and product development testing in addition to expanded pre-clinical microbiology testing. 

The expansion allows Stryker to add more capabilities and accommodate for the future growth of R&D across a variety of procedures. This advanced facility, spanning 55,600 square feet across three floors, serves as a key enabler for accelerating innovation from India for local and global markets. "This new lab represents our commitment to developing medical technologies that improve patient outcomes and comply with the highest regulatory standards," said Ram Rangarajan, Vice President of Stryker Global Technology Center, India.

The new lab features include:

  • Prototyping and product assurance hub: Equipped with state-of-the-art infrastructure for plastic 3D printing, metal machining, and a diverse range of testing capabilities, the lab supports prototyping and product development across Stryker’s entire product portfolio.
  • Expanded microbiology competency: The lab strengthens Stryker’s ability to conduct comprehensive microbiological testing as part of the product development process.
  • Talented team of engineers and microbiologists: Highly skilled engineers and microbiologists will use the advanced equipment and expertise to develop innovative solutions that positively impact patients around the world.